Thomas Edward Hamilton - 27 Feb 2026 Form 4 Insider Report for Larimar Therapeutics, Inc. (LRMR)

Role
Director
Signature
/s/ Jennifer Johansson, Attorney-in-fact
Issuer symbol
LRMR
Transactions as of
27 Feb 2026
Net transactions value
+$500,000
Form type
4
Filing time
02 Mar 2026, 16:30:41 UTC
Previous filing
15 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hamilton Thomas Edward Director C/O LARIMAR THERAPEUTICS, INC., THREE BALA PLAZA EAST, SUITE 506, BALA CYNWYD /s/ Jennifer Johansson, Attorney-in-fact 02 Mar 2026 0001769848

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LRMR Common Stock Purchase $500,000 +100,000 +18% $5.00 664,798 27 Feb 2026 Direct F1
holding LRMR Common Stock 159,433 27 Feb 2026 Post Edison, LLC
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock purchased in the underwritten offering of Larimar Therapeutics, Inc. at the offering price, which closed on February 27, 2026.